Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance
Comparative Acute Effects of Caffeine Delivery Forms (Capsule, Chewing Gum, Mouth Rinse) on Aerobic Capacity and Wingate Anaerobic Performance Outcomes in Recreational Male Athletes: A Randomized Counterbalanced Crossover Trial
1 other identifier
interventional
14
1 country
1
Brief Summary
This study investigated the effects of different caffeine delivery forms on aerobic and anaerobic exercise performance in healthy adults. Participants completed experimental trials involving caffeine capsule ingestion, caffeine gum chewing, and caffeine mouth rinse conditions. Aerobic performance was assessed using maximal oxygen uptake (VO2max), and anaerobic performance was evaluated using the Wingate anaerobic test. The study used a randomized crossover design where each participant completed all experimental conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2025
CompletedFirst Submitted
Initial submission to the registry
March 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedMarch 27, 2026
March 1, 2026
1 month
March 23, 2026
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Aerobic Capacity (VO2max)
Description: Estimated maximal oxygen uptake calculated via the 20-meter shuttle run test (Beep Test).Metric: Milliliters per kilogram per minute (ml/kg/min)
Measured after each 48-hour washout period following the specific caffeine or placebo intervention
Aerobic Capacity (VO2max)
Estimated maximal oxygen uptake calculated via the 20-meter shuttle run test (Beep Test).
Measured after each 48-hour washout period following the specific caffeine or placebo intervention
Anaerobic Average Power
The mean power output maintained over the duration of a 30-second Wingate Anaerobic Test
Measured after each 48-hour washout period following the specific caffeine or placebo intervention.
Study Arms (3)
Caffeine Capsule
EXPERIMENTALParticipants ingest 300 mg of anhydrous caffeine in tablet form with 100 mL of water exactly 60 minutes prior to exercise. This timing is selected to allow for gastrointestinal absorption and to reach peak plasma concentration.
Caffeine Gum
EXPERIMENTALParticipants chew caffeinated gum (containing 300 mg of caffeine) for 5 minutes, finishing just before the exercises begin. This method utilizes rapid transmucosal absorption through the oral mucosa to potentially bypass first-pass metabolism.
Caffeine Mouth Rinse
EXPERIMENTALParticipants rinse with 25 mL of a 1.2% caffeine solution (containing 300 mg of caffeine) for 10 seconds immediately before the exercises and then expectorate the solution completely. Swallowing is strictly prohibited to ensure the effect is triggered primarily through oropharyngeal receptors rather than systemic absorption.
Interventions
This study evaluates the acute effects of three distinct caffeine delivery methods compared to a placebo, using a standardized total dose of 300 mg of caffeine across all active interventions. The study is a randomized, single-blind, counterbalanced crossover trial involving 14 recreational male athletes. The interventions are distinguished by their specific absorption kinetics and ecologically valid administration timings
Eligibility Criteria
You may qualify if:
- Being a healthy male recreational athlete between the ages of 18-25.
- Having at least 2 years of regular training history (3-4 days per week).
- Being a non-smoker and having no chronic diseases or musculoskeletal injuries.
- Willingness to abstain from caffeine, alcohol, and strenuous exercise 48 hours before each test session.
You may not qualify if:
- Having a known allergy or sensitivity to caffeine.
- Using any other performance-enhancing supplements during the study period.
- Failure to adhere to the standardized nutritional or sleep requirements before testing.
- Inability to complete all four experimental trials (Capsule, Gum, Rinse, Placebo).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziantep University, Faculty of Sport Science (Athletic Performance Laboratory)
Şehitkamil, Gaziantep, 27310, Turkey (Türkiye)
Related Publications (10)
https://doi.org/10.5812/asjsm.34607
BACKGROUNDhttps://doi.org/10.1007/s40279-017-0776-1
BACKGROUNDhttps://doi.org/10.1080/17461391.2019.1601261
BACKGROUNDhttps://doi.org/10.1007/s40279-014-0257-8
BACKGROUNDhttps://doi.org/10.1136/bjsports-2018-100278
BACKGROUNDhttps://doi.org/10.3390/medicina57010008
BACKGROUNDhttps://doi.org/10.1007/s40279-017-0848-2
BACKGROUNDhttps://doi.org/10.1186/s12970-020-00383-4
BACKGROUNDhttps://doi.org/10.2478/hukin-2021-0070
BACKGROUNDhttps://doi.org/10.23751/pn.v25i3.14659
BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
March 23, 2026
First Posted
March 27, 2026
Study Start
October 10, 2024
Primary Completion
November 10, 2024
Study Completion
March 10, 2025
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
The individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices), will be made available to researchers who provide a methodologically sound proposal. Data will be available beginning 6 months and ending 36 months following publication. Requests should be directed to mehmetvrl27@hotmail.com. To gain access, data requestors will need to sign a data access agreement.